The Journal of Urology
Volume 178, Issue 6 , Page 2377, December 2007

Editorial Comment

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

published online 15 October 2007.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(07)02314-2

doi:10.1016/j.juro.2007.08.114

Refers to article:

  • Phase II Study of Ketoconazole Plus Granulocyte-Macrophage Colony-Stimulating Factor for Prostate Cancer: Effect of Extent of Disease on Outcome , 15 October 2007

    Charles J. Ryan, Vivian Weinberg, Jonathan Rosenberg, Lawrence Fong, Amy Lin, Jennifer Kim, Eric J. Small
    The Journal of Urology December 2007 (Vol. 178, Issue 6, Pages 2372-2377)

The Journal of Urology
Volume 178, Issue 6 , Page 2377, December 2007

Article Tools